Delivery Order SPE2DB22D1017-SPE2DB25FYSKQ
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,076.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.26 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on May 27, 2025. This competitively awarded, firm fixed-price delivery order is structured with an ultimate completion date of May 28, 2025, and carries no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a delivery order valued at $32,094.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,753.64 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,915.41 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed price, competitively awarded contract with a completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract contains no set-aside designation, reflecting open competition among qualified vendors....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,702.70 for Teriparatide 560mcg/2.24ml pen on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections with a ceiling value of $5,443.66. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates as...
- The Defense Logistics Agency awarded a delivery order valued at $7,313.71 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This competitively awarded, firm fixed price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply...